Sheila Seleri

Sheila Seleri is an experienced medical executive with a robust background in neuroscience and clinical development. Currently serving as Executive Medical Director at Genentech since October 2015, Sheila has held roles as Group Medical Director and Principal Medical Director - Neuroscience. Prior to this, Sheila worked at Takeda Pharmaceuticals in various capacities including Global Program Leader and Senior Medical Director - Clinical Development. Sheila's earlier experience includes positions at Takeda Pharmaceuticals International, Inc., Takeda Global Research and Development Center, Inc., Bristol-Myers Squibb, and Eli Lilly and Company. Sheila's expertise includes the development of mood disorder franchises, significantly focusing on medications such as Prozac, Olanzapine, and Cymbalta. Education was completed at USP - Universidade de São Paulo, earning an MD from 1990 to 1996.